If passed, the EPIC Act would remove the so-called “pill penalty,” which poses a strong disincentive against developing small-molecule drugs, Thomas Kaiser, co-founder and chief scientific officer at ...

One thing a closer examination might have uncovered was the fact that the slow release mechanism was easy to get around – because it was the coating on the pill that made it slow release.